Moreover, as FEN1 regulates the expression and function of many molecules, there may be additional effects of FEN1 inhibition that contribute to sensitization of glioma cells to DNA-PKcs dysfunction, either cooperating with BRCA1/2, RAD51 or WRN. This evidence concerns the gene WRN and central nervous system cancer.